28/05/2024  21:48:02 Var. +0.030 Volume Denaro28/05/2024 Lettera28/05/2024 Capitalizzazione di mercato Dividend Y. Rapporto P/E
1.020EUR +3.03% 0
Fatturato: 0.000
-Quantità in denaro: - -Quantità in lettera: - 7.64 mill.EUR 0.00% -

Descrizione business

Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Marc Lloret-Grau
Consiglio di amministrazione
Thomas Konradt
Consiglio di sorveglianza
Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt
 

Dati aziendali

Name: Bio-Gate AG
Indirizzo: Neumeyerstraße 28-34,D-90411 Nürnberg
Telefono: +49-911-4775-23–100
Fax: +49-911-4775-23–101
E-mail: info@bio-gate.de
Internet: www.bio-gate.de/
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 18.30%
Data dell'IPO: 05/04/2006

Rapporti con gli investitori

Name: Gerd Rückel
IR telefono: +49-6172-807-309
IR Fax: -
IR e-mail: presse@bio-gate.de

Principali azionisti

Synthos GmbH
 
46.30%
Freefloat
 
18.30%
Mountain Technology AG
 
15.80%
Eiffel Investment Group
 
8.40%
Richter / RFH Ltd.
 
7.30%
Gründer / Management
 
3.90%